
DNAmito's proprietary DNA technology and vendor-agnostic cloud platform help clinicians deliver more precise radiation therapy and improve patient outcomes.
The DNAmito team is comprised of world class genomics and data scientists, accomplished entrepreneurs, software and product developers, clinical and industry experts, bringing years of experience and success to the company. They cultivate our strong innovative culture and work tirelessly to help our team to scale and succeed.The DNAmito strategic advisory team has a wealth of experience in medical research, clinical oncology and regulatory. The members of the strategic advisory team come from leading academic institutions, medical practices as well as medical device companies.DNAmito has a strategic partnership and licensing agreement with the Maastro Clinic and Maastricht University. Through this partnership, DNAmito has access to leading cancer research centers in Europe, Asia and the U.S.

The current clinical practice in radiation therapy does not differentiate the dose for each patient. The genetic test offered by DNAmito gives a reliable indication of the complication risk of radiation toxicity and thereby direct the patients to the type of radiation therapy that minimizes radiation to healthy tissue. It also indicates the possibility of higher dose when the patient can tolerate it, thereby increasing the effectiveness of treatment.
DNAmito's proprietary DNA technology and cloud platform deliver measurable improvements in clinical outcomes and operational efficiency for cancer treatment.
100%
Vendor-agnostic platform
DNAmito integrates seamlessly with existing industry standards, avoiding vendor lock-in for healthcare providers.
1
Proprietary DNA technology
Our single, unified approach to radiation treatment planning delivers precision across all cancer care scenarios.
15+
Years of combined expertise
Our team brings decades of experience in genomics, data science, and clinical innovation to every solution.
Palo Alto
Headquarters location
Based in California's innovation hub, DNAmito drives forward-thinking oncology solutions for global healthcare systems.
Reach out to discuss how our DNA-guided radiation technology can enhance clinical outcomes at your facility.